Related Experiment Video
Updated: Jun 24, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
Ferroptosis inhibitors: past, present and future
Lei Zhang1, Yi Lin Luo1, Yang Xiang2
1School of Medicine, Yan'an University, Yan'an, China.
Ferroptosis, a cell death form driven by iron and lipid peroxidation, is linked to neurodegeneration and organ damage. This review explores ferroptosis inhibitors and therapies for future drug discovery.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Ferroptosis is a distinct, iron-dependent programmed cell death pathway.
- Its mechanisms and role in diseases like neurodegeneration are increasingly understood.
- Targeting ferroptosis offers potential therapeutic strategies.
Purpose of the Study:
- To detail ferroptosis metabolic pathways.
- To review natural and synthetic small molecule ferroptosis inhibitors.
- To discuss emerging therapies and clinical translation challenges.
Main Methods:
- Literature review of ferroptosis mechanisms and inhibitors.
- Analysis of therapeutic approaches including gene therapy, cell therapy, and nanotechnology.
- Exploration of ferroptosis's relationship with other cell death modalities.
Main Results:
- Ferroptosis involves specific metabolic pathways and lipid peroxidation.
- Various small molecule inhibitors show efficacy in disease models.
- Gene therapy, cell therapy, and nanomedicine represent novel treatment avenues.
Conclusions:
- Ferroptosis inhibition is a promising therapeutic strategy for various diseases.
- Understanding ferroptosis's interplay with other cell death types is crucial for drug design.
- Clinical translation of ferroptosis inhibitors faces challenges but holds significant potential.
More Related Videos
09:21Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts
Published on: February 23, 2024
08:02Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
Published on: May 14, 2021
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...